StockComparison Logo
vs

GYRE vs CVII

Comparison between Gyre Therapeutics Inc (GYRE, Company) and Churchill Capital Corp VII - Class A (CVII, Company).

GYRE is from the Healthcare sector, while CVII is from the Financial Services sector.

5-Year PerformanceCVII has outperformed GYRE, delivering a return of +0.5% compared to -6.6%

GYRE vs CVII - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
GYRE
$571M
CVII
$570M
Max Drawdown
GYRE
99.99%
Winner
CVII
19.11%
Sharpe Ratio
Winner
GYRE
-0.21
CVII
-0.25
5Y Beta
GYRE
1.43
Winner
CVII
-0.05
Industry
GYRE
Biotechnology
CVII
Shell Companies
P/E Ratio
GYRE
-155.37
Winner
CVII
-366.18
Forward P/E
GYRE
78.12
CVII
N/A
5Y EPS CAGR
GYRE
-58.01%
CVII
N/A
Debt to Equity
GYRE
0.00%
CVII
0.00%
Free Cash Flow Yield
Winner
GYRE
0.54%
CVII
-3.30%
P/B Ratio
GYRE
N/A
CVII
-8.91

GYRE vs CVII - Historical Returns

Returns include dividend reinvestment.

1M
GYRE
-2.95%
Winner
CVII
+0.00%
3M
GYRE
-10.84%
Winner
CVII
+0.00%
6M
GYRE
-14.97%
CVII
N/A
1Y
GYRE
-24.97%
CVII
N/A
5Y(CAGR)
GYRE
-6.61%
Winner
CVII
+0.55%
10Y(CAGR)
GYRE
-18.57%
CVII
N/A
Max(CAGR)
GYRE
-22.80%
Winner
CVII
+0.27%

GYRE vs CVII - Annual Returns (2006 - 2026)

Returns include dividend reinvestment.

YearGYRECVII
2026-8.22%+0.00%
2025-41.17%N/A
2024-49.14%-4.86%
2023+460.43%+5.11%
2022+103.46%+1.42%
2021-85.16%-0.20%
2020-2.92%N/A
2019-17.45%N/A
2018-45.09%N/A
2017+37.88%N/A
2016-78.82%N/A
2015-72.50%N/A
2014-36.78%N/A
2013-11.13%N/A
2012-22.06%N/A
2011-79.22%N/A
2010+29.33%N/A
2009+472.60%N/A
2008-56.74%N/A
2007-10.22%N/A
2006+4.50%N/A

GYRE vs CVII Drawdown Comparison

The maximum drawdown for GYRE was -99.98%, occurring on May 13, 2022. This drawdown has not yet recovered.

The maximum drawdown for CVII was -19.11%, occurring on Aug 16, 2024. This drawdown has not yet recovered.

The current GYRE drawdown is -99.84%. The current CVII drawdown is -19.11%.

RankGYRECVII
#1-99.98%
Mar 3, 2011 - May 13, 2022
-19.11%
Aug 12, 2024 - Aug 16, 2024
#2-84.89%
Jul 27, 2007 - Jul 28, 2009
-4.17%
Jul 17, 2023 - Jun 26, 2024
#3-38.22%
Apr 12, 2006 - Dec 27, 2006
-2.82%
May 5, 2021 - Oct 26, 2022
#4-25.89%
May 3, 2010 - Oct 25, 2010
-1.21%
Apr 8, 2021 - May 4, 2021
#5-21.70%
Dec 4, 2009 - Apr 28, 2010
-1.01%
Jun 12, 2023 - Jul 17, 2023
#6-20.27%
Oct 16, 2009 - Nov 23, 2009
-0.80%
Oct 26, 2022 - Jan 10, 2023
#7-19.38%
Oct 7, 2009 - Oct 16, 2009
-0.40%
Feb 6, 2023 - Mar 13, 2023
#8-15.74%
Nov 4, 2010 - Dec 16, 2010
-0.37%
Jun 26, 2024 - Jul 31, 2024
#9-15.72%
Feb 23, 2007 - Apr 24, 2007
-0.37%
Aug 7, 2024 - Aug 9, 2024
#10-13.66%
Jul 29, 2009 - Aug 7, 2009
-0.20%
Jan 30, 2023 - Feb 6, 2023
#11-11.04%
Sep 30, 2009 - Oct 7, 2009
-0.20%
Mar 27, 2023 - Apr 14, 2023
#12-11.02%
May 22, 2007 - Jul 27, 2007
-0.18%
Jul 31, 2024 - Aug 5, 2024
#13-9.23%
Jan 14, 2011 - Feb 28, 2011
-0.15%
May 1, 2023 - May 5, 2023
#14-7.93%
Jan 3, 2007 - Feb 23, 2007
-0.15%
May 17, 2023 - May 30, 2023
#15-7.04%
Dec 1, 2009 - Dec 4, 2009
-0.15%
Jun 2, 2023 - Jun 12, 2023

Correlation

Correlation between GYRE and CVII is 0.64 which considered as a moderate positive correlation - the stocks show some tendency to move together.

0.64
-101

Select Stocks to Compare